Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Defining the borders of splenic marginal zone lymphoma: a multiparameter study.

Dufresne SD, Felgar RE, Sargent RL, Surti U, Gollin SM, McPhail ED, Cook JR, Swerdlow SH.

Hum Pathol. 2010 Apr;41(4):540-51. doi: 10.1016/j.humpath.2009.09.007. Epub 2009 Dec 11.

3.

Splenic marginal zone lymphoma.

Dogan A, Isaacson PG.

Semin Diagn Pathol. 2003 May;20(2):121-7. Review.

PMID:
12945935
4.

Primary nodal marginal zone lymphomas of splenic and MALT type.

Campo E, Miquel R, Krenacs L, Sorbara L, Raffeld M, Jaffe ES.

Am J Surg Pathol. 1999 Jan;23(1):59-68.

PMID:
9888704
5.

[Clinicopathologic study of splenic marginal zone B-cell lymphoma].

Zhang YN, Zheng YY, Zhou XG, Zhang SH, Jin Y, Xie JL, Chen SY, Shi Y, Wu LH.

Zhonghua Bing Li Xue Za Zhi. 2009 Apr;38(4):243-7. Chinese.

PMID:
19575895
6.

CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.

Baseggio L, Traverse-Glehen A, Petinataud F, Callet-Bauchu E, Berger F, Ffrench M, Couris CM, Thieblemont C, Morel D, Coiffier B, Salles G, Felman P.

Haematologica. 2010 Apr;95(4):604-12. doi: 10.3324/haematol.2009.011049. Epub 2009 Dec 16.

7.

Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.

Hoehn D, Miranda RN, Kanagal-Shamanna R, Lin P, Medeiros LJ.

Hum Pathol. 2012 Nov;43(11):1828-38. doi: 10.1016/j.humpath.2012.01.003. Epub 2012 Apr 18.

PMID:
22520947
8.

Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.

Watkins AJ, Huang Y, Ye H, Chanudet E, Johnson N, Hamoudi R, Liu H, Dong G, Attygalle A, McPhail ED, Law ME, Isaacson PG, de Leval L, Wotherspoon A, Du MQ.

J Pathol. 2010 Mar;220(4):461-74. doi: 10.1002/path.2665.

PMID:
20077527
9.

Karyometric comparison of splenic and gastric marginal zone lymphomas.

Styczeń M, Szpor J, Demczuk S, Okoń K.

Anal Cell Pathol (Amst). 2012;35(4):297-303. doi: 10.3233/ACP-2012-0064.

10.

MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.

Hamadeh F, MacNamara SP, Aguilera NS, Swerdlow SH, Cook JR.

Mod Pathol. 2015 Apr;28(4):564-74. doi: 10.1038/modpathol.2014.120. Epub 2014 Sep 12.

11.

Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features.

Dierlamm J, Pittaluga S, Wlodarska I, Stul M, Thomas J, Boogaerts M, Michaux L, Driessen A, Mecucci C, Cassiman JJ, De Wolf-Peeters C, Van den Berghe H.

Blood. 1996 Jan 1;87(1):299-307.

12.

Outcome and prognostic factors in ocular adnexal lymphoma.

Nola M, Lukenda A, Bollmann M, Kalauz M, Petrovecki M, Bollmann R.

Croat Med J. 2004 Jun;45(3):328-32.

13.

Splenic small B-cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma?

Mollejo M, Algara P, Mateo MS, Sánchez-Beato M, Lloret E, Medina MT, Piris MA.

Histopathology. 2002 Jan;40(1):22-30.

PMID:
11903595
14.

[Marginal zone lymphomas: extranodal MALT type, nodal and splenic].

Dallenbach FE, Coupland SE, Stein H.

Pathologe. 2000 Mar;21(2):162-77. Review. German.

PMID:
10840821
15.
16.

Primary nodal marginal zone lymphomas of splenic and MALT type.

Nathwani BN, Drachenberg MR, Hernandez AM.

Am J Surg Pathol. 2000 Feb;24(2):317-9. No abstract available.

PMID:
10680907
17.

Characteristics of CD5-positive splenic marginal zone lymphoma with leukemic manifestation ; clinical, flow cytometry, and histopathological findings of 11 cases.

Kojima M, Sato E, Oshimi K, Murase T, Koike T, Tsunoda S, Matsumoto T, Marutsuka K, Ogiya D, Moriuchi M, Tokunaka M, Yara Kikuti Y, Kikuchi T, Nakamura N, Ando K.

J Clin Exp Hematop. 2010;50(2):107-12.

18.

Splenic involvement by aggressive malignant lymphomas of B-cell and T-cell types. A morphologic and immunophenotypic study.

Stroup RM, Burke JS, Sheibani K, Ben-Ezra J, Brownell M, Winberg CD.

Cancer. 1992 Jan 15;69(2):413-20.

19.

Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification.

Traverse-Glehen A, Baseggio L, Salles G, Felman P, Berger F.

Curr Opin Oncol. 2011 Sep;23(5):441-8. doi: 10.1097/CCO.0b013e328349ab8d. Review.

PMID:
21760505
20.

Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients.

Berger F, Felman P, Thieblemont C, Pradier T, Baseggio L, Bryon PA, Salles G, Callet-Bauchu E, Coiffier B.

Blood. 2000 Mar 15;95(6):1950-6.

Supplemental Content

Support Center